News
Greater Fort Lauderdale Alliance Annual Meeting Announces Fiscal Year 2025 Achievements: Jobs Growth, Company Expansions
Aviation MRO & Pharmaceutical Manufacturing Sectors Continue Robust Growth in Broward; Alan B. Levan Receives Top Business Leadership Award; Stanley Cup Makes a Special Appearance
FORT LAUDERDALE, Fla. (October 9, 2025) - The Greater Fort Lauderdale Alliance, Broward County’s official public-private partnership for economic development, held its 2025 Annual Meeting, presented by Amazon, the Florida Panthers, and PMI US, at the War Memorial Auditorium in Fort Lauderdale on Thursday, Oct. 9 with more than 600 business and community leaders in attendance. Invited guests of the private event enjoyed an exclusive opportunity to take photos with the Stanley Cup.
During the Annual Meeting, the Alliance announced several company expansions and relocations to Broward County in its 2024-25 fiscal year, which ended September 30, and reported assisting businesses in creating 716 new high-value jobs, retaining 211 jobs, and securing more than $139 million in new capital investment.
Additionally, the Alliance announced a major new life sciences project for the upcoming 2026 fiscal year: global pharmaceutical leader, Lupin, will construct a new pharmaceutical manufacturing plant in Coral Springs, which will anchor the company’s U.S. production of critical respiratory therapies and generate more than 200 new long-term skilled jobs by 2030 in Broward County. With a projected cumulative investment of more than $250 million, including research and development, infrastructure, and capital investment, Lupin’s new state-of-the-art Coral Springs facility will have the capacity to accommodate the production of more than 25 critical respiratory medicines, diversifying the supply chain, strengthening domestic manufacturing, and enhancing medicine security and affordable, reliable access.
Alliance projects announced in Fiscal Year 2025 include:
CTS Engines, a global leader in mature aviation engine maintenance, opened its new 216,000-square foot Maintenance, Repair, and Overhaul (MRO) “Engine Hub” facility in Coral Springs on September 24, which will serve as the company’s global headquarters and more than double its space and output capacity. The company was assisted by the Alliance in 2025 in creating 41 new high-skill jobs and making a capital investment of $2.5 million. This is in addition to the company's initial $17 million expansion, announced in 2024, which created 125 jobs. “This is the only new engine center in the world purpose-built to overhaul, repair, and test legacy engines. With a total capacity of up to 200 engines a year, this facility and the CTS team are focused on supporting our global customer base, both commercial and military, with world-class quality and turnaround times,” said CTS Engines CEO Bill Kircher. Steven Wasserman of Colliers assisted CTS Engines in securing the lease. Chris Metzger of Cushman & Wakefield represented the landlord.
Decoral System USA, decorative powder coating technology pioneers and creators of the Decoral sublimation process for metal decoration, opened a 56,000-square foot manufacturing facility in Coral Springs, creating 50 new jobs.
ESG (Event Services Group), which provides décor and services for special events, relocated to a new 66,000-square foot Fort Lauderdale facility, expanding its production warehouse and office space, and adding 50 new jobs, with a capital investment of $1 million.
Fly Legacy, a pilot training company, retained five jobs by relocating to a new 3,000-square foot classroom, office, and hangar space at a Sheltair facility in Pompano Airpark in Pompano Beach.
NakAI Robotics, an Israeli manufacturer of autonomous robots for commercial ship hull inspection and cleaning, is opening a new 2,000-square foot manufacturing facility in Fort Lauderdale, creating five new jobs and investing $300,000.
Pherros Biosciences, a pharmaceutical manufacturing company in Deerfield Beach, is in the midst of a multi-phase expansion that will allow for the production of up to 100,000 units of new and generic injectable medicines
Show Other Stories
